Lung cancer is by far the most common cause of cancer death in the UK. It is a common condition typically presented at a late stage. Late diagnosis of lung cancer is a leading cause of poor cancer survival outcomes in the UK.

RM Partners data analysis revealed areas within west London of high incidence of lung cancer; low rates of diagnosis at the early stages of lung cancer (stages 1 and 2); high rates of diagnosis at stage 4, and low one-year survival rates for patients with lung cancer.

We are supporting three projects to improve earlier diagnosis of lung cancer across west London.

  • The Targeted Lung Health Check (TLHC) project takes a proactive approach by detecting cancer at an early stage in patients who are asymptomatic.
  • The local implementation of the National Optimal Lung Cancer Pathway (NOLCP) aims to improve the delivery of reactive diagnostic pathways once patients are symptomatic.
  • The management of pulmonary nodule project aims to standardise approaches to improving prompt diagnosis of cancerous nodules and improving patient experience.

Targeted Lung Health Check Project

National Optimal Lung Cancer Pathway

Management of Pulmonary Nodules